Your browser doesn't support javascript.
loading
Postprandial Hypertriglyceridaemia Revisited in the Era of Non-fasting Lipid Profiles: Executive Summary of a 2019 Expert Panel Statement.
Kolovou, Genovefa D; Watts, Gerald F; Mikhailidis, Dimitri P; Pérez-Martínez, Pablo; Mora, Samia; Bilianou, Helen; Panotopoulos, George; Katsiki, Niki; Ooi, Teik C; Lopez-Miranda, José; Tybjærg-Hansen, Anne; Tentolouris, Nicholas; Nordestgaard, Børge G.
Afiliação
  • Kolovou GD; Cardiology Department and LDL-Apheresis Unit, Onassis Cardiac Surgery Center, Athens, Greece.
  • Watts GF; Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Crawley, Australia.
  • Mikhailidis DP; Department of Clinical Biochemistry, Royal Free Hospital Campus, University College London Medical School, University College London (UCL), London, United Kingdom.
  • Pérez-Martínez P; Lipid and Atherosclerosis Unit, IMIBIC/Reina Sofia University Hospital/University of Cordoba, and CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Mora S; Center for Lipid Metabolomics, Divisions of Preventive and Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
  • Bilianou H; Department of Cardiology, Tzanio Hospital, Piraeus, Greece.
  • Panotopoulos G; Department of Obesity and Metabolism, Hygeia Hospital, Athens, Greece.
  • Katsiki N; First Department of Internal Medicine, Division of Endocrinology-Metabolism, Diabetes Center, AHEPA University Hospital, Thessaloniki, Greece.
  • Ooi TC; Department of Medicine, Division of Endocrinology and Metabolism, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Lopez-Miranda J; Lipid and Atherosclerosis Unit, IMIBIC/Reina Sofia University Hospital/University of Cordoba, and CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Tybjærg-Hansen A; Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Tentolouris N; First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece.
  • Nordestgaard BG; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Curr Vasc Pharmacol ; 17(5): 538-540, 2019.
Article em En | MEDLINE | ID: mdl-31418346
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Triglicerídeos / Análise Química do Sangue / Doenças Cardiovasculares / Hipertrigliceridemia / Período Pós-Prandial Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Curr Vasc Pharmacol Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Triglicerídeos / Análise Química do Sangue / Doenças Cardiovasculares / Hipertrigliceridemia / Período Pós-Prandial Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Curr Vasc Pharmacol Ano de publicação: 2019 Tipo de documento: Article